Vaccines to be used against antibiotic-resistant typhoid
Uganda, Malawi and Zimbabwe are the three high-burden African countries selected to be the first to benefit from a conjugate vaccine for drug-resistant typhoid.
Professor Kathleen Neuzil, the director of Centre for Vaccine Development at University of Maryland in the US, one of the research partners, said the vaccine is currently under trial in Malawi to test whether it is equally effective in Africa.
"If qualified by the World Health Organisation, it will also help to lessen antibiotic resistance besides preventing the typhoid fever," Neuzil said.
Other countries where the same vaccine trials are being conducted include Nepal and Bangladesh, both located on the South India continent.
Source: The Monitor